ElaineRMorganMD

Pediatric Hematology & Oncology • Chicago, IL

Hospice and Palliative Medicine(Pediatric Hematology and Oncology)

Professor in Pediatrics, Northwestern University Medical School

Join to view full profile

Dr. Morgan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Morgan's full profile

Already have an account?

Office
225 E Chicago Avenue
Lurie Childrens Hospital
Chicago, IL 60611
Phone+1 312-227-4090

Fax+1 312-227-9377

Education & Training

Children's Hospital Los AngelesResidency, Pediatrics, 1971 - 1974
Perelman School of Medicine at the University of PennsylvaniaClass of 1971
Boston Children’s Hospital/Boston Medical CenterFellowship, Hospice and Palliative Medicine

Certifications & Licensure

CA State Medical License 1973 - Present
IL State Medical License 1976 - 2026
WI State Medical License 2004 - 2019
PA State Medical License 1975 - 1990
American Board of Pediatrics Pediatrics
American Board of Pediatrics Hospice and Palliative Medicine
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
Chicago Magazine: Top Doctors Castle Connolly, 2006, 2012, 2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Chicago Mag - Children's Health Castle Connolly, 2010
Super Doctor SuperDoctors.com
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01

Publications & Presentations

PubMed

Malakoplakia: A rare cause of hematochezia in pediatric patients.
Ariel Porto, Jonathan Lebowitz, Robert Byrd, Elaine Morgan, Joshua D Prozialeck
JPGN Reports. 2024-08-01
14 citations
Access to Technology and Preferences for an mHealth Intervention to Promote Medication Adherence in Pediatric Acute Lymphoblastic Leukemia: Approach Leveraging Behavio...
Mallorie B Heneghan, Tasmeen Hussain, Leonardo Barrera, Stephanie W. Cai, Maureen Haugen
Journal of Medical Internet Research. 2021-02-18
13 citations
Applying the COM‐B model to patient‐reported barriers to medication adherence in pediatric acute lymphoblastic leukemia
Mallorie B. Heneghan, Tasmeen Hussain, Leonardo Barrera, Stephanie W. Cai, Maureen Haugen
Pediatric Blood & Cancer. 2020-02-18